MIRRX THERAPEUTICS A/S

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0218,360 OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITYApr 07, 17Aug 03, 17[C12N]
2010/0021,914 OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITYNov 23, 07Jan 28, 10[C07H, C12Q]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9879255 Modulation of RNA activity and vascular permeabilityOct 02, 13Jan 30, 18[A61K, C07H, C12N]
9290767 Oligonucleotides for modulation of target RNA activityAug 20, 15Mar 22, 16[C07H, C12N]
9145557 Oligonucleotides for modulation of target RNA activityNov 23, 11Sep 29, 15[C07H, C12N]
8951984 Oligonucleotides for modulation of target RNA activityApr 07, 14Feb 10, 15[A61K, C07H, C12Q, C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0079,505 BIVALENT ANTISENSE OLIGONUCLEOTIDESAbandonedMar 24, 11Mar 28, 13[C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.